Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Adaptive Islet Biology and Incretin Physiology: Emerging Perspectives From Asia and Europe

Journal article

HODSON D. and Nasteska D., (2026), Journal of Diabetes Investigation

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.

Journal article

Gharahdaghi N. et al, (2026), The New England journal of medicine, 394, 2212 - 2222

PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.

Journal article

Lugo-Palacios DG. et al, (2026), Health technology assessment (Winchester, England), 30, 1 - 28

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study.

Journal article

Boiko O. et al, (2026), Diabetic medicine : a journal of the British Diabetic Association, 43

Bionano Interface Optimization for Rational Lateral Flow Assay Development.

Journal article

Sadler CJ. et al, (2026), ACS nano

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer.

Journal article

Lopez-Janeiro A. et al, (2026), The Journal of clinical investigation, 136

A temporal dialogue between the circadian clock and chronic inflammatory diseases.

Journal article

Chen S. and Ray D., (2026), Disease models & mechanisms, 19

Load More